Stay updated on Durvalumab Combinations in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combinations in NSCLC Clinical Trial page
- Check5 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the history list.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the earlier funding-lapse notice (v3.4.1).SummaryDifference0.5%

- Check77 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check84 days agoChange DetectedAdded a 'Show glossary' option and color-coded legends explaining additions (green) and deletions (red). Updated the revision tag from v3.3.4 to v3.4.0 and added No FEAR Act Data.SummaryDifference0.7%

Stay in the know with updates to Durvalumab Combinations in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.